Publications by authors named "Curt D Furberg"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

392,568

Total Likes

8,698

Extended Reach

754,555

Social Features

50
R
Relations of change in plasma levels of LDL-C, non-HDL-C and apoB with risk reduction from statin therapy: a meta-analysis of randomized trials.
George Thanassoulis, Ken Williams, Keying Ye, Robert Brook, Patrick Couture, Patrick R Lawler, Jacqueline de Graaf, Curt D Furberg, Allan Sniderman

April 2014

Videos about Article: user user

2 2 33

View All Article and Social Media Activity
A
A meta-analysis of low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B as markers of cardiovascular risk.
Allan D Sniderman, Ken Williams, John H Contois, Howard M Monroe, Matthew J McQueen, Jacqueline de Graaf, Curt D Furberg

Circ Cardiovasc Qual Outcomes· May 2011

Videos about Article: user user

2 13

View All Article and Social Media Activity
S
Sick Individuals and Sick Populations by Geoffrey Rose: Cardiovascular Prevention Updated.
Allan D Sniderman, George Thanassoulis, John T Wilkins, Curt D Furberg, Michael Pencina

J Am Heart Assoc· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diabetes and Cognitive Decline in Older Adults: The Ginkgo Evaluation of Memory Study.
Priya Palta, Michelle C Carlson, Rosa M Crum, Elizabeth Colantuoni, A Richey Sharrett, Curt D Furberg

J Gerontol A Biol Sci Med Sci· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An evidence-based analysis of the National Lipid Association recommendations concerning non-HDL-C and apoB.
Allan D Sniderman, Peter P Toth, George Thanassoulis, Curt D Furberg

J Clin Lipidol· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unsuccessfully Treated Hypertension: A Major Public Health Problem With a Potential Solution.
Curt D Furberg, Jean E Sealey, Jon D Blumenfeld

Am J Hypertens· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heterogeneity in Early Responses in ALLHAT (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial).
Sanket S Dhruva, Chenxi Huang, Erica S Spatz, Andreas C Coppi, Frederick Warner, Curt D Furberg

Hypertension· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Harms of Antipsychotic Drugs: Evidence from Key Studies.
Thomas J Moore, Curt D Furberg

Drug Saf· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Age and Cardiovascular Risk Attributable to Apolipoprotein B, Low-Density Lipoprotein Cholesterol or Non-High-Density Lipoprotein Cholesterol.
Allan D Sniderman, Shofiqul Islam, Matthew McQueen, Michael Pencina, Curt D Furberg

J Am Heart Assoc· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Completeness of serious adverse drug event reports received by the US Food and Drug Administration in 2014.
Thomas J Moore, Curt D Furberg, Donald R Mattison, Michael R Cohen

Pharmacoepidemiol Drug Saf· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lipoprotein-Associated Phospholipase A2 and Incident Peripheral Arterial Disease in Older Adults: The Cardiovascular Health Study.
Parveen K Garg, Alice M Arnold, Karen D Hinckley Stukovsky, Carol Koro, Nancy S Jenny, Curt D Furberg

Arterioscler Thromb Vasc Biol· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Apolipoprotein B improves risk assessment of future coronary heart disease in the Framingham Heart Study beyond LDL-C and non-HDL-C.
Michael J Pencina, Ralph B D'Agostino, Tomasz Zdrojewski, Ken Williams, George Thanassoulis, Curt D Furberg

Eur J Prev Cardiol· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Risk-Benefit Paradigm vs the Causal Exposure Paradigm: LDL as a primary cause of vascular disease.
Peter P Toth, George Thanassoulis, Ken Williams, Curt D Furberg, Allan Sniderman

J Clin Lipidol· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is the Guideline Process Replicable and, if Not, What Does This Mean?
Allan Sniderman, Curt D Furberg, Peter P Toth, George Thanassoulis

Prog Cardiovasc Dis· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Electronic Health Data for Postmarket Surveillance: A Vision Not Realized.
Thomas J Moore, Curt D Furberg

Drug Saf· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma renin testing to guide antihypertensive therapy.
Anthony J Viera, Curt D Furberg

Curr Hypertens Rep· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
J
JNC 8: shortcomings in process and treatment recommendations.
Curt D Furberg, Michael H Alderman

Am J Hypertens· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Linked publications from a single trial: a thread of evidence.
Douglas G Altman, Curt D Furberg, Jeremy M Grimshaw, Daniel R Shanahan

Trials· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Introduction. Tribute to John Laragh, MD - clinician and scientific researcher.
Curt D Furberg

Am J Hypertens· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A pilot test of a new tool for remote blood pressure monitoring.
Kurt Boman, Andre Brenander, Mats Gustavsson, Curt D Furberg

J Telemed Telecare· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Taking a longer term view of cardiovascular risk: the causal exposure paradigm.
Allan D Sniderman, Peter P Toth, George Thanassoulis, Michael J Pencina, Curt D Furberg

BMJ· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Republished: pro-arrhythmic and pro-ischaemic effects of inhaled anticholinergic medications.
Sonal Singh, Yoon K Loke, Paul Enright, Curt D Furberg

Postgrad Med J· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development times, clinical testing, postmarket follow-up, and safety risks for the new drugs approved by the US food and drug administration: the class of 2008.
Thomas J Moore, Curt D Furberg

JAMA Intern Med· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tiotropium and the risk of death in COPD.
Yoon K Loke, Sonal Singh, Curt D Furberg

N Engl J Med· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of hospitalized gastrointestinal bleeding in persons randomized to diuretic, ACE-inhibitor, or calcium-channel blocker in ALLHAT.
William Phillips, Linda B Piller, Jeff D Williamson, Jeffrey Whittle, Syed Z A Jafri, Curt D Furberg

J Clin Hypertens (Greenwich)· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The necessity for clinical reasoning in the era of evidence-based medicine.
Allan D Sniderman, Kevin J LaChapelle, Nikodem A Rachon, Curt D Furberg

Mayo Clin Proc· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis